β 2 -microglobulin amyloidosis

Subcellular Biochemistry

Volumn 65, Issue , 2012, Pages 517-540

  Corlin, Dorthe B ^a   Heegaard, Niels H H ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

A 2 m; Dialysis related amyloidosis; 2 microglobulin

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; COMPLEMENT; COPPER;

AMYLOIDOSIS; ANIMAL; BLOOD; CHEMISTRY; CHRONIC KIDNEY FAILURE; COMPLEMENT ACTIVATION; HUMAN; METABOLISM; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE; RENAL REPLACEMENT THERAPY; REVIEW; UREMIA;

AMYLOID; AMYLOIDOSIS; ANIMALS; BETA 2-MICROGLOBULIN; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; COPPER; HUMANS; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; UREMIA;

EID: 84887264660     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-5416-4_19     Document Type: Article

References (187)

1. Adamski-Werner SL, Palaninathan SK, Sacchettini JC, Kelly JW (2004) Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis. J Med Chem 47:355-374
2. Ahn M, Kang S, Koo HJ, Lee JH, Lee YS, Paik SR (2010) Nanoporous protein matrix made of amyloid fibrils of beta2-microglobulin. Biotechnol Prog 26:1759-1764
3. Annuk M, Soveri I, Zilmer M, Lind L, Hulthe J, Fellstrom B (2005) Endothelial function, CRP and oxidative stress in chronic kidney disease. J Nephrol 18:721-726.
4. ArgilesA, Mourad G,Axelrud-Cavadore C,WatrinA, Mion C, Cavadore JC (1989) High-molecularmass proteins in haemodialysis-associated amyloidosis. Clin Sci (Lond) 76:547-552
5. ArgilesA, Derancourt J, Jauregui-Adell J, Mion C, Demaille JG (1992) Biochemical characterization of serum and urinary beta 2 microglobulin in end-stage renal disease patients. Nephrol Dial Transplant 7:1106-1110
6. Argiles A, Garcia-Garcia M, Derancourt J, Mourad G, Demaille JG (1995) Beta 2 microglobulin isoforms in healthy individuals and in amyloid deposits. Kidney Int 48:1397-1405
7. Assenat H, Calemard E, Charra B, Laurent G, Terrat JC, Vanel T (1980) Hémodialyse, syndrome du canal carpien et substance amylöıd. Nouv Presse Med 24:1715
8. Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE, Bush AI (2000) Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J Neurochem 75:1219-1233
9. Azinas S, Colombo M, Barbiroli A et al (2011) D-strand perturbation and amyloid propensity in beta-2 microglobulin. FEBS J 278:2349-2358
10. Barbet-Massin E, Ricagno S, Lewandowski JR, Giorgetti S, Bellotti V, Bolognesi M, Emsley L, Pintacuda G (2010) Fibrillar vs crystalline full-length beta-2-microglobulin studied by highresolution solid-state NMR spectroscopy. J Am Chem Soc 132:5556-5557
11. Bartl R, Frisch B, Diem H, Mundel M, Fateh-Moghadam A (1989) Bone marrow histology and serum beta 2 microglobulin in multiple myeloma-a new prognostic strategy. Eur J Haematol Suppl 51:88-98
12. Baz M, Durand C, Ragon A, Jaber K, Andrieu D, Merzouk T, Purgus R, Olmer M, Reynier JP, Berland Y (1991) Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 14:681-685
13. Bellotti V, Stoppini M, Mangione P, Sunde M, Robinson C, Asti L, Brancaccio D, Ferri G (1998) Beta2-microglobulin can be refolded into a native state from ex vivo amyloid fibrils. Eur J Biochem 258:61-67
14. Berggård I (1965) Identification and isolation of urinary proteins. In: Peeters H (ed) Protides of the biological fluids (Proceedings of the 12th Colloquium, Bruges, 1964), Elsevier, Amsterdam, pp 285-291
15. Berggard I, Bearn AG (1968) Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids. J Biol Chem 243:4095-4103
16. Bhalla RB, Safai B, Pahwa S, Schwartz MK (1985) Beta 2-microglobulin as a prognostic marker for development of AIDS. Clin Chem 31:1411-1412
17. Bjorck L, Akerstrom B, Berggard I (1979) Occurrence of beta 2-microglobulin in mammalian lymphocytes and erythrocytes. Eur J Immunol 9:486-490
18. Borysik AJ, Morten IJ, Radford SE, Hewitt EW (2007) Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions. Kidney Int 72:174-181
19. Bourantas KL, Hatzimichael EC, Makis AC, Chaidos A, Kapsali ED, Tsiara S, Mavridis A (1999) Serum beta-2-microglobulin, TNF-alpha and interleukins in myeloproliferative disorders. Eur J Haematol 63:19-25
20. Brancaccio D, Gallieni M, Niwa T, Braidotti P, Coggi G (2000) Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis. J Nephrol 13:129-136
21. Buchholz NP, Moch H, Gasser TC, Linke RP, Thiel GT, Mihatsch MJ (1995) Ureteral amyloid deposits of beta 2-microglobulin origin in both kidney recipients of 1 donor. J Urol 153:399-401
22. Calabrese MF, Eakin CM, Wang JM, Miranker AD (2008) A regulatable switch mediates selfassociation in an immunoglobulin fold. Nat Struct Mol Biol 15:965-971
23. Campistol JM, Torregrosa JV, Ponz E, Fenollosa B (1999) Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes. Contrib Nephrol 125:76-85
24. Canale C, Relini A, GliozziA (2011) Atomic force microscopy of ex vivo amyloid fibrils. Methods Mol Biol 736:81-95
25. Castillo GM, Cummings JA, Yang W, Judge ME, Sheardown MJ, Rimvall K, Hansen JB, Snow AD (1998) Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes 47:612-620
26. Charra B, Calemard F, Uzan M, Terrat JC, Vanel T, Laurent G (1984) Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term hemodialysis patients. Proc Eur DialTransplant Assoc 21:291-295
27. Cheung AK, Rocco MV,Yan G et al (2006) Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 17:546-555
28. Cohlberg JA, Li J, Uversky VN, Fink AL (2002) Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. Biochemistry 41:1502-1511
29. Colombo M, Ricagno S, BarbiroliA, Santambrogio C, Giorgetti S, Raimondi S, Bonomi F, Grandori R, BellottiV, BolognesiM (2011) The effects of an ideal beta-turn on beta-2 microglobulin fold stability. J Biochem 150:39-47
30. Corazza A, Pettirossi F, Viglino P et al (2004) Properties of some variants of human beta2- microglobulin and amyloidogenesis. J Biol Chem 279:9176-9189
31. Corlin DB, Sen JW, Ladefoged S, Lund GB, Nissen MH, Heegaard NH (2005) Quantification of cleaved b2-microglobulin in serum from patients undergoing chronic hemodialysis. Clin Chem 51:1177-1184
32. Corlin DB, Johnsen CK, Nissen MH, Heegaard NH (2009) A beta2-microglobulin cleavage variant fibrillates at near-physiological pH. Biochem Biophys Res Commun 381:187-191
33. Corlin DB, Johnsen CK, Nissen MH, Heegaard NH (2010) Glycosaminoglycans enhance the fibrillation propensity of the beta2-microglobulin cleavage variant-DeltaK58-beta2m. Biochem Biophys Res Commun 402:247-251
34. Cresswell P, Springer T, Strominger JL, Turner MJ, Grey HM, Kubo RT (1974) Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci U S A 71:2123-2127
35. Danesh F, Ho LT (2001) Dialysis-related amyloidosis: history and clinical manifestations. Semin Dial 14:80-85
36. Davis DP, Gallo G, Vogen SM, Dul JL, Sciarretta KL, Kumar A, Raffen R, Stevens FJ, Argon Y (2001) Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain. J Mol Biol 313:1021-1034
37. De Lorenzi E, Colombo R, Sabella S, Corlin DB, Heegaard NH (2008) The influence of Cu(2+) on the unfolding and refolding of intact and proteolytically processed beta(2)-microglobulin. Electrophoresis 29:1734-1740
38. Debelouchina GT, Platt GW, Bayro MJ, Radford SE, Griffin RG (2010) Intermolecular alignment in beta(2)-microglobulin amyloid fibrils. J Am Chem Soc. [Epub ahead of print]
39. Deng NJ, Yan L, Singh D, Cieplak P (2006) Molecular basis for the Cu2+ binding-induced destabilization of beta2-microglobulin revealed by molecular dynamics simulation. Biophys J 90:3865-3879
40. Doherty PC, Zinkernagel RM (1975) H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J Exp Med 141:502-507
41. Domanska K, Vanderhaegen S, Srinivasan V et al (2011) Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta2-microglobulin variant. Proc Natl Acad Sci U S A 108:1314-1319
42. Drueke TB, Massy ZA (2009) Beta2-microglobulin. Semin Dial 22:378-380
43. EakinCM,MirankerAD (2005) From chance to frequent encounters: origins of beta2-microglobulin fibrillogenesis. Biochim Biophys Acta 1753:92-99
44. Eakin CM, Knight JD, Morgan CJ, Gelfand MA, MirankerAD (2002) Formation of a copper specific binding site in non-native states of beta-2-microglobulin. Biochemistry 41:10646-10656
45. Eakin CM, Attenello FJ, Morgan CJ, Miranker AD (2004) Oligomeric assembly of native-like precursors precedes amyloid formation by beta-2 microglobulin. Biochemistry 43:7808-7815
46. Eakin CM, Berman AJ, Miranker AD (2006) A native to amyloidogenic transition regulated by a backbone trigger. Nat Struct Mol Biol 13:202-208
47. Ecroyd H, Thorn DC, LiuY, Carver JA (2010) The dissociated form of kappa-casein is the precursor to its amyloid fibril formation. Biochem J 429:251-260
48. Eichner T, Radford SE (2009) A generic mechanism of beta2-microglobulin amyloid assembly at neutral pH involving a specific proline switch. J Mol Biol 386:1312-1326
49. Eichner T, Radford SE (2011) Understanding the complex mechanisms of beta(2) -microglobulin amyloid assembly. FEBS J 278:3868-3883
50. Esposito G, Michelutti R, Verdone G et al (2000) Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci 9:831-845
51. Esposito G, Ricagno S, Corazza A et al (2008) The controlling roles of Trp60 and Trp95 in beta2- microglobulin function, folding and amyloid aggregation properties. J Mol Biol 378:887-897
52. Fabian H, Gast K, Laue M, Misselwitz R, Uchanska-Ziegler B, Ziegler A, Naumann D (2008) Early stages of misfolding and association of beta2-microglobulin: insights from infrared spectroscopy and dynamic light scattering. Biochemistry 47:6895-6906
53. Feder JN, Tsuchihashi Z, Irrinki A et al (1997) The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 272:14025- 14028
54. Floege J, Ehlerding G (1996) Beta-2-microglobulin-associated amyloidosis. Nephron 72:9-26
55. Fujimori A (2011) Beta-2-microglobulin as a uremic toxin: the Japanese experience. Contrib Nephrol 168:129-33. [Epub 2010, Oct 7]
56. Garcia-Garcia M, Gouin-Charnet A, Mourad G, Argilés A (1997) Monomeric and dimeric b2- microglobulin may be extracted from amyloid deposits in vitro. Nephrol Dial Transplant 12:1192-1198
57. Gejyo F, Yamada T, Odani S et al (1985) A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun 129:701- 706
58. Gejyo F, Homma N, Suzuki Y, Arakawa M (1986) Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 314:585-586
59. Giorgetti S, Rossi A, Mangione P et al (2005) Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. Protein Sci 14:696-702
60. Giorgetti S, Stoppini M, Tennent GA et al (2007) Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysisrelated amyloidosis. Protein Sci 16:343-349
61. Giorgetti S, Raimondi S, Pagano K et al (2011) Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils. J Biol Chem 286:2121-2131
62. Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, Millett PJ, Lee DM (2007) High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 9:R36
63. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383:550-553
64. Gorevic PD, Casey TT, Stone WJ, DiRaimondo CR, Prelli FC, Frangione B (1985) Beta- 2 microglobulin is an amyloidogenic protein in man. J Clin Invest 76:2425-2429
65. Gorevic PD, Munoz PC, Casey TT, DiRaimondo CR, Stone WJ, Prelli FC, Rodrigues MM, Poulik MD, Frangione B (1986) Polymerization of intact b2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci U S A 83:7908-7912
66. Gouin-Charnet A, Laune D, Granier C, Mani JC, Pau B, Mourad G, Argiles A (2000) Alpha2- macroglobulin, the main serum antiprotease, binds beta2-microglobulin, the light chain of the class I major histocompatibility complex, which is involved in human disease. Clin Sci (Lond) 98:427-433
67. Gumperz JE (2006) The ins and outs of CD1 molecules: bringing lipids under immunological surveillance. Traffic 7:2-13
68. Hafner-Bratkovic I, Bester R, Pristovsek P et al (2011) Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion. J Biol Chem 286:12149- 12156
69. Hasegawa K, Tsutsumi-Yasuhara S, Ookoshi T, Ohhashi Y, Kimura H, Takahashi N, Yoshida H, Miyazaki R, Goto Y, Naiki H (2008) Growth of beta(2)-microglobulin-related amyloid fibrils by non-esterified fatty acids at a neutral pH. Biochem J 416:307-315
70. Hashimoto N, Naiki H, Gejyo F (1999) Modification of beta 2-microglobulin with D-glucose or 3-deoxyglucosone inhibits A beta 2M amyloid fibril extension in vitro. Amyloid 6:256-264
71. HeegaardNH (2009) Beta(2)-microglobulin: from physiology to amyloidosis. Amyloid 16:151-173
72. Heegaard NH, Roepstorff P, Melberg SG, NissenMH (2002) Cleaved beta 2-microglobulin partially attains a conformation that has amyloidogenic features. J Biol Chem 277:11184-11189
73. Heegaard NHH, Jørgensen TJD, Rozlosnik N, Corlin DB, Pedersen JS, TempestaAG, Roepstorff P, Bauer R, Nissen MH (2005) Unfolding, aggregation, and seeded amyloid formation of Lysine- 58-cleaved b2-microglobulin. Biochemistry 44:4397-4407
74. Hodkinson JP, Jahn TR, Radford SE, Ashcroft AE (2009) HDX-ESI-MS reveals enhanced conformational dynamics of the amyloidogenic protein beta(2)-microglobulin upon release from the MHC-1. J Am Soc Mass Spectrum 20:278-286
75. Hoshino M, Katou H, Hagihara Y, Hasegawa K, Naiki H, Goto Y (2002) Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nat Struct Biol 9:332-336
76. Jackson RL, Busch SJ, Cardin AD (1991) Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 71:481-539
77. Jackson GS, Murray I, Hosszu LL, Gibbs N, Waltho JP, Clarke AR, Collinge J (2001) Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci U S A 98:8531-8535
78. Jadoul M (1998) Dialysis-related amyloidosis: importance of biocompatibility and age. Nephrol Dial Transplant 13(Suppl 7):61-64
79. Jadoul M, Garbar C, Noel H, Sennesael J,Vanholder R, Bernaert P, Rorive G, Hanique G, vanYpersele de SC (1997) Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int 51:1928-1932
80. Jahn TR, Parker MJ, Homans SW, Radford SE (2006) Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat Struct Mol Biol 13:195-201
81. Jahn TR, Makin OS, Morris KL, Marshall KE, Tian P, Sikorski P, Serpell LC (2010) The common architecture of cross-beta amyloid. J Mol Biol 395:717-727
82. Jones S, Manning J, Kad NM, Radford SE (2003) Amyloid-forming peptides from beta2- microglobulin-Insights into the mechanism of fibril formation in vitro. J Mol Biol 325:249-257
83. Jørgensen TJD, Cheng L, Heegaard NHH (2007) Mass spectrometric characterization of conformational preludes to b2-microglobulin aggregation. 268:207-216
84. Kad NM, Thomson NH, Smith DP, Smith DA, Radford SE (2001) Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J Mol Biol 313:559-571
85. Kameda A, Hoshino M, Higurashi T, Takahashi S, Naiki H, Goto Y (2005) Nuclear magnetic resonance characterization of the refolding intermediate of beta2-microglobulin trapped by non-native prolyl peptide bond. J Mol Biol 348:383-397
86. Kang SJ, Cresswell P (2002) Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J Biol Chem 277:44838-44844
87. Kardos J, Micsonai A, Pal-Gabor H, Petrik E, Graf L, Kovacs J, Lee YH, Naiki H, GotoY (2011) Reversible heat-induced dissociation of beta2-microglobulin amyloid fibrils. Biochemistry 19(50):3211-3220
88. Karlsson FA, Wibell L, Evrin PE (1980) b2-microglobulin in clinical medicine. Scand J Clin Lab Invest 40(Suppl 154):27-37
89. Kawano M, Muramoto H, Yamada M, Minamoto M, Araki H, Koni I, Mabuchi H, Nonomura A (1998) Fatal cardiac beta2-microglobulin amyloidosis in patients on long-term hemodialysis. Am J Kidney Dis 31:E4
90. Khan AR, Baker BM, Ghosh P, Biddison WE, Wiley DC (2000) The structure and stability of an HLA-A+0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site. J Immunol 164:6398-6405
91. Kinoshita CM, GewurzAT, Siegel JN,Ying SC, Hugli TE, Coe JE, Gupta RK, Huckman R, Gewurz H (1992) A protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins. Protein Sci 1:700-709
92. Kiss E, Keusch G, Zanetti M, Jung T, Schwarz A, Schocke M, Jaschke W, Czermak BV (2005) Dialysis-related amyloidosis revisited. AJR Am J Roentgenol 185:1460-1467
93. Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK,Yee VC (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 8:770-774
94. Kuntz D, Naveau B, Bardin T, Drueke T, Treves R, Dryll A (1984) Destructive spondylarthropathy in hemodialyzed patients. A new syndrome. Arthritis Rheum 27:369-375
95. Kwon HK, Pyun SB, Cho WY, Boo CS (2011) Carpal tunnel syndrome and peripheral polyneuropathy in patients with end stage kidney disease. J Korean Med Sci 26:1227-1230
96. Labriola L, Garbar C, Jadoul M (2007) Persistence of beta2-microglobulin amyloidosis 20 years after successful kidney transplantation. Am J Kidney Dis 50:167-168
97. Lee S, Eisenberg D (2003) Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process. Nat Struct Biol 10:725-730
98. Lee DM, Jackson KW, Knowlton N, Wages J, Alaupovic P, Samuelsson O, Saeed A, Centola M, Attman PO (2011) Oxidative stress and inflammation in renal patients and healthy subjects. PLoS ONE 6:e22360.
99. Linke RP, Bommer J, Ritz E,Waldherr R, EulitzM (1986)Amyloid kidney stones of uremic patients consist of beta 2-microglobulin fragments. Biochem Biophys Res Commun 136:665-671
100. Linke RP, Hampl H, Bartel-Schwarze S, EulitzM (1987) Beta 2-microglobulin, different fragments and polymers thereof in synovial amyloid in long-term hemodialysis. Biol Chem Hoppe Seyler 368:137-144
101. Linke RP, Hampl H, Lobeck H, Ritz E, Bommer J, Waldherr R, Eulitz M (1989) Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int 36:675-681
102. Liu C, Sawaya MR, Eisenberg D (2011) beta-Microglobulin forms three-dimensional domainswapped amyloid fibrils with disulfide linkages. Nat Struct Mol Biol 18:49-55
103. Liu H, Chumsae C, Gaza-Bulseco G, Hurkmans K, Radziejewski CH (2010) Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis. Anal Chem 82:5219-5226
104. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D (1999) Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int 55:286-293
105. Magnus JH, StenstadT,Kolset SO, HusbyG (1991) Glycosaminoglycans in extracts of cardiac amyloid fibrils from familial amyloid cardiomyopathy of Danish origin related to variant transthyretin Met 111. Scand J Immunol 34:63-69
106. McParland VJ, Kad NM, Kalverda AP, Brown A, Kirwin-Jones P, Hunter MG, Sunde M, Radford SE (2000) Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. Biochemistry 39:8735-8746
107. MendozaVL,Antwi K, Baron-RodriguezMA,Blanco C,VachetRW (2010) Structure of the preamyloid dimer of beta-2-microglobulin from covalent labeling and mass spectrometry. Biochemistry 49:1522-1532
108. Mendoza VL, Baron-Rodriguez MA, Blanco C, Vachet RW (2011) Structural insights into the pre-amyloid tetramer of beta-2-microglobulin from covalent labeling and mass spectrometry. Biochemistry 50:6711-6722
109. Mimmi MC, Jorgensen TJ, Pettirossi F et al (2006) Variants of beta-microglobulin cleaved at lysine- 58 retain the main conformational features of the native protein but are more conformationally heterogeneous and unstable at physiological temperature. FEBS J 273:2461-2474
110. MiuraY, IshiyamaT, InomataA,TakedaT, Senma S, Okuyama K, SuzukiY (1992) Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis. Nephron 60:268-273
111. Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T (1993) beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252
112. Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM (1996) Identification of pentosidine as a native structure for advanced glycation end products in b2- microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci U S A 93:2353-2358
113. Mogyorosi A, Schubert ML (1999) Dialysis-related amyloidosis: an important cause of gastrointestinal symptoms in patients with end-stage renal disease. Gastroenterology 116:217-220
114. Morgan CJ, Gelfand M, Atreya C, Miranker AD (2001) Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation. J Mol Biol 309:339-345
115. MotomiyaY, AndoY, Haraoka K, Sun X, Iwamoto H, Uchimura T, Maruyama I (2003) Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients. Kidney Int 64:2244-2252
116. Mount SL, Eltabbakh GH, Hardin NJ (2002) Beta-2 microglobulin amyloidosis presenting as bilateral ovarian masses: a case report and review of the literature.AmJ Surg Pathol 26:130-133
117. Mourad G, ArgilesA (1996) Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis. J Am Soc Nephrol 7:798-804
118. Myers SL, Jones S, Jahn TR, Morten IJ, Tennent GA, Hewitt EW, Radford SE (2006) A systematic study of the effect of physiological factors on b2-microglobulin amyloid formation at neutral pH. Biochemistry 45:2311-2321
119. Naiki H, Gejyo F, Nakakuki K (1997) Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 36:6243-6250
120. Nilsson M, Wang X, Rodziewicz-Motowidlo S, Janowski R, Lindstrom V, Onnerfjord P, Westermark G, Grzonka Z, Jaskolski M, Grubb A (2004) Prevention of domain swapping inhibits dimerization and amyloid fibril formation of cystatin C: use of engineered disulfide bridges, antibodies, and carboxymethylpapain to stabilize the monomeric form of cystatin C. J Biol Chem 279:24236-24245
121. Nissen MH, Thim L, Christensen M (1987) Purification and biochemical characterization of the complete structure of a proteolytically modified beta-2-microglobulin with biological activity. Eur J Biochem 163:21-28
122. Nissen MH, Roepstorff P, Thim L, Dunbar B, Fothergill JE (1990) Limited proteolysis of beta 2-microglobulin at Lys-58 by complement component C1s. Eur J Biochem 189:423-429
123. Nissen MH, Johansen B, Bjerrum OJ (1997) A simple method for the preparation and purification of C1 complement cleaved beta 2-microglobulin from human serum. J Immunol Methods 205:29- 33
124. Niwa T, Katsuzaki T, Momoi T, Miyazaki T, Ogawa H, Saito A, Miyazaki S, Maeda K, Tatemichi N, Takei Y (1996) Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum. Kidney Int 49:861-867
125. Niwa T, Katsuzaki T, Miyazaki S, Momoi T, Akiba T, Miyazaki T, Nokura K, Hayase F, Tatemichi N, Takei Y (1997) Amyloid b2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis. Kidney Int 51:187-194
126. Niwa T, Tsukushi S (2001) 3-Deoxyglucosone and AGEs in uremic complications: inactivation of glutathione peroxidase by 3-deoxyglucosone. Kidney Int Suppl 78:S37-S41
127. Odani H, Oyama R, Titani K, Ogawa H, Saito A (1990) Purification and complete amino acid sequence of novel b2-microglobulin. Biochem Biophys Res Commun 168:1223-1229
128. Ogawa H, SaitoA, Oda O, NakajimaM,ChungTG (1988) Detection of novel beta 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition. Clin Nephrol 30:158- 163
129. OhhashiY, Kihara M, Naiki H, GotoY (2005) Ultrasonication-induced amyloid fibril formation of beta2-microglobulin. J Biol Chem 280:32843-32848
130. Okon M, Bray P, Vucelic D (1992) 1H NMR assignments and secondary structure of human beta 2-microglobulin in solution. Biochemistry 31:8906-8915
131. Otten GR, Bikoff E, Ribaudo RK, Kozlowski S, Margulies DH, Germain RN (1992) Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression. J Immunol 148:3723-3732
132. Ozawa D,Yagi H, Ban T, Kameda A, Kawakami T, Naiki H, GotoY (2009) Destruction of amyloid fibrils of a beta2-microglobulin fragment by laser beam irradiation. J Biol Chem 284:1009-1017
133. Ozawa D, Hasegawa K, Lee YH, Sakurai K, Yanagi K, Ookoshi T, Goto Y, Naiki H (2011a) Inhibition of beta2-microglobulin amyloid fibril formation by alpha2-macroglobulin. J Biol Chem 286:9668-9676
134. Ozawa D, KajiY,Yagi H, Sakurai K, Kawakami T, Naiki H, GotoY (2011b) Destruction of amyloid fibrils of keratoepithelin peptides by laser irradiation coupled with amyloid-specific thioflavin T. J Biol Chem 286:10856-10863
135. Pedersen JT, Østergaard J, Rozlosnik N, Gammelgaard B, Heegaard NH (2011) Cu(II) mediates kinetically distinct, non-amyloidogenic aggregation of amyloid-beta peptides. J Biol Chem 286:26952-26963
136. Pepys MB (2006) Amyloidosis. Annu Rev Med 57:223-241
137. Platt GW, Routledge KE, Homans SW, Radford SE (2008) Fibril growth kinetics reveal a region of beta2-microglobulin important for nucleation and elongation of aggregation. J Mol Biol 378:251-263
138. Praetor A, Hunziker W (2002) beta(2)-Microglobulin is important for cell surface expression and pH-dependent IgG binding of human FcRn. J Cell Sci 115:2389-2397
139. Regazzoni L, Colombo R, Bertoletti L et al (2011) Screening of fibrillogenesis inhibitors of beta2- microglobulin: integrated strategies by mass spectrometry capillary electrophoresis and in silico simulations. Anal Chim Acta 685:153-161
140. Relini A, Canale C, De SS et al (2006) Collagen plays an active role in the aggregation of beta2- microglobulin under physiopathological conditions of dialysis-related amyloidosis. J Biol Chem 281:16521-16529
141. Richardson JS, Richardson DC (2002) Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci U S A 99:2754-2759
142. Sacchettini JC, Kelly JW (2002) Therapeutic strategies for human amyloid diseases. Nat Rev Drug Discov 1:267-275
143. Saito A, Pietromonaco S, Loo AK, Farquhar MG (1994) Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci U S A 91:9725-9729
144. Sambashivan S, Liu Y, Sawaya MR, Gingery M, Eisenberg D (2005) Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure. Nature 437:266-269
145. Santambrogio C, Ricagno S, Colombo M, Barbiroli A, Bonomi F, BellottiV, Bolognesi M, Grandori R (2010) DE-loop mutations affect beta2 microglobulin stability, oligomerization, and the lowpH unfolded form. Protein Sci 19:1386-1394
146. Saper MA, Bjorkman PJ, Wiley DC (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6A resolution. J Mol Biol 219:277-319
147. Sasahara K,Yagi H, Naiki H, GotoY (2007) Heat-induced conversion of beta(2)-microglobulin and hen egg-white lysozyme into amyloid fibrils. J Mol Biol 372:981-991
148. Schneider A, Drechsler C, KraneV, Krieter DH, Scharnagl H, Schneider MP,Wanner C (2011) The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study. Clin J Am Soc Nephrol 7(1):52-59
149. Schwalbe S, HolzhauerM,Schaeffer J, GalanskiM,KochKM,Floege J (1997) Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis? Kidney Int 52:1077-1083
150. Shimizu S, Yasui C, Yasukawa K, Nakamura H, Shimizu H, Tsuchiya K (2003) Subcutaneous nodules on the buttocks as a manifestation of dialysis-related amyloidosis: a clinicopathological entity? Br J Dermatol 149:400-404
151. Skinner M, Pepys MB, Cohen AS, Heller LM, Lian JB (1980) In: Freitas AF de, Glenner GG, Costa PP (eds) Amyloid and amyloidosis: proceedings of the Third International Symposium on Amyloidosis, Póvoa de Varzim, Portugal, 23-28 September 1979. Amsterdam: Excerpta Medica, pp 384-391
152. Smith DP, Jones S, Serpell LC, Sunde M, Radford SE (2003) A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation. J Mol Biol 330:943-954
153. Snow AD, Kisilevsky R (1985) Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study. Lab Invest 53:37-44
154. Snow AD, Willmer J, Kisilevsky R (1987) A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils. Lab Invest 57:687-698
155. Snow AD, Mar H, Nochlin D, Kimata K, Kato M, Suzuki S, Hassell J, Wight TN (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 133:456-463
156. SnowAD, Bramson R, Mar H,Wight TN, Kisilevsky R (1991) A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem 39:1321-1330
157. Stoppini MS, Arcidiaco P, Mangione P, Giorgetti S, Brancaccio D, Bellotti V (2000) Detection of fragments of beta2-microglobulin in amyloid fibrils. Kidney Int 57:349-350
158. Stoppini M, Mangione P, Monti M et al (2005) Proteomics of beta2-microglobulin amyloid fibrils. Biochim Biophys Acta 1753:23-33
159. Takayama F, Miyazaki S, Morita T, HirasawaY, Niwa T (2001) Dialysis-related amyloidosis of the heart in long-term hemodialysis patients. Kidney Int Suppl 78:S172-S176
160. Tang X, Sadeghi M, Olumee Z, Vertes A, Braatz JA, McIlwain LK, Dreifuss PA (1996) Detection and quantitation of beta-2-microglobulin glycosylated end products in human serum by matrixassisted laser desorption/ionization mass spectrometry. Anal Chem 68:3740-3745
161. Tennent GA, Lovat LB, Pepys MB (1995) Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A 92:4299-4303
162. Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K, Matsushima M, Nakayama M, Hosoya T, Era S (2004) Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 66:1988-1993
163. Treuhaft PS, MCCarty DJ (1971) Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheum 14:475-484
164. Trinh CH, Smith DP, Kalverda AP, Phillips SE, Radford SE (2002) Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties. Proc Natl Acad Sci U S A 99:9771-9776
165. Uversky VN, Li J, Fink AL (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J Biol Chem 276:44284-44296
166. van Ypersele S, Jadoul M, Malghem J, Maldague B, Jamart J (1991) Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. TheWorking Party on Dialysis Amyloidosis. Kidney Int 39:1012-1019
167. Verdone G, Corazza A, Viglino P, Pettirossi F, Giorgetti S, Mangione P, Andreola A, Stoppini M, Bellotti V, Esposito G (2002) The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition. Protein Sci 11:487-499
168. Villanueva J, Hoshino M, Katou H, Kardos J, Hasegawa K, Naiki H, Goto Y (2004) Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis. Protein Sci 13:797-809
169. Vincent C, Dennoroy L, Revillard J-P (1994) Molecular variants of b2-microglobulin in renal insufficiency. Biochem J 298:181-187
170. Vorbeck-Meister I, Sommer R,Vorbeck F, HorlWH (1999) Quality ofwater used for haemodialysis: bacteriological and chemical parameters. Nephrol Dial Transplant 14:666-675
171. Wahlbom M, Wang X, Lindstrom V, Carlemalm E, Jaskolski M, Grubb A (2007) Fibrillogenic oligomers of human cystatin C are formed by propagated domain swapping. J Biol Chem 282:18318-18326
172. Warren DJ, Otieno LS (1975) Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgrad Med J 51:450-452
173. White HE, Hodgkinson JL, Jahn TR, Cohen-Krausz S, Gosal WS, Muller S, Orlova EV, Radford SE, Saibil HR (2009) Globular tetramers of beta(2)-microglobulin assemble into elaborate amyloid fibrils. J Mol Biol 389:48-57
174. Williams DB, Barber BH, Flavell RA, Allen H (1989) Role of beta 2-microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules. J Immunol 142:2796-2806
175. Winchester JF, Salsberg JA, Levin NW (2003) Beta-2 microglobulin in ESRD: an in-depth review. Adv Ren Replace Ther 10:279-309
176. Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145:1030-1035
177. Woods LA, Platt GW, Hellewell AL, Hewitt EW, Homans SW, Ashcroft AE, Radford SE (2011) Ligand binding to distinct states diverts aggregation of an amyloid-forming protein. Nat Chem Biol 7:730-739
178. Wu AHB (2006) Tietz Clinical Guide to Laboratory Tests, 4th edn. Saunders, St. Louis
179. Yamaguchi I, Suda H, Tsuzuike N et al (2003) Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro. Kidney Int 64:1080-1088
180. Yamamoto S, Hasegawa K,Yamaguchi I, Tsutsumi S, Kardos J, GotoY, Gejyo F, Naiki H (2004a) Low concentrations of sodium dodecyl sulfate induce the extension of beta 2-microglobulinrelated amyloid fibrils at a neutral pH. Biochemistry 43:11075-11082
181. Yamamoto S, Yamaguchi I, Hasegawa K, Tsutsumi S, Goto Y, Gejyo F, Naiki H (2004b) Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulinrelated amyloid fibrils at a neutral pH. J Am Soc Nephrol 15:126-133
182. Yamamoto K,Yagi H, Ozawa D, Sasahara K, Naiki H, GotoY (2008) Thiol compounds inhibit the formation of amyloid fibrils by beta 2-microglobulin at neutral pH. J Mol Biol 376:258-268
183. Yamamoto S, Kazama JJ, Narita I, Naiki H, Gejyo F (2009) Recent progress in understanding dialysis-related amyloidosis. Bone. 45(Suppl 1):S39-S42. [Epub 2009, Mar 19]
184. Young ID,Willmer JP, Kisilevsky R (1989) The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis. Acta Neuropathol 78:202-209
185. Young ID, Ailles L, Narindrasorasak S, Tan R, Kisilevsky R (1992) Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus. Arch Pathol Lab Med 116:951-954
186. Zhang P, Fu X, Sawashita J et al (2010) Mouse model to study human A beta 2M amyloidosis: generation of a transgenic mouse with excessive expression of human beta2-microglobulin. Amyloid 17:50-62
187. + cytolytic T cells. Nature 443:742-746